Essential fatty acid (omega-3 / omega-6) supplements in dogs with atopic dermatitis — MAYBE (weak evidence)

In dogs with atopic dermatitis, do omega-3/omega-6 essential fatty acid supplements vs placebo improve coat, lesions, and itch — or spare other drugs?

Shelf #279 · gate-verified and displayed under the developer's blinded-trial rule

MAYBE (weak evidence): The signals are real but none of the three blinded trials lands its primary question cleanly. The largest and most direct test, Saevik 2004 (60 atopic dogs, randomised, double-blind, placebo-controlled, 12 weeks of borage seed oil plus fish oil on top of prednisolone), found prednisolone use was lower in the supplemented group but not statistically significantly so (P = 0.32) — the steroid-sparing claim failed its primary comparison (the treatment made no statistically significant difference), with significance appearing only in sequentially sliced late windows from day 64 (P = 0.04). Bond & Lloyd 1992 showed that atopic dogs previously controlled on an evening primrose oil / fish oil combination mostly deteriorated when switched blind to olive oil (8 of 10) while 9 of 11 who stayed on the combination were unchanged — evidence the supplement was doing something in those preselected responders, but a withdrawal design, not a test of starting supplements. Scarff & Lloyd 1992 (double-blind placebo-controlled crossover, 35 dogs) found a significant treatment effect on erythema only (P < 0.05). Together: a modest effect on some skin signs in some dogs is plausible; improved coat, broad lesion/itch control, and steroid sparing are not established. Drafted Nov 10, 2026 (VetMed build, topic #279); all figures from abstracts fetched and verified at drafting.

Saevik 2004: fatty acids on top of prednisolone — steroid use lower but not significantly (P = 0.32); late-window difference from day 64 (P = 0.04)

Randomized, double blind, placebo-controlled multicentre clinical trial (record's own abstract wording; indexed Randomized Controlled Trial)

Who: Dogs: 60 dogs with atopic dermatitis in a multicentre trial (record MeSH indexes Denmark, Finland, Norway and Sweden) — randomly assigned to a combination of borage seed oil and fish oil or placebo for 12 weeks, in addition to prednisolone tablets whose dosage owners adjusted to the recorded pruritus score (10 cm visual analog scale) according to written instructions; all dogs received a standardized basal diet, and investigators graded skin lesions at days 0, 42 and 84.

Result: The use of prednisolone during the test period was lower in the active group, but the difference was not statistically significant (P = 0.32) (the treatment made no statistically significant difference on the primary steroid-sparing comparison). When the test period was sequentially divided into windows ending at day 84, the difference between the active and placebo groups reached statistical significance on day 64 (P = 0.04), with an increasing difference towards the end of the study. A statistically significant reduction in pruritus scores and total clinical scores from day 0 to day 84 was apparent in both groups (P < 0.0001), and at the end of the study both the pruritus score and the total clinical score were lower in the active group (the record gives no figures for that between-group difference). The record concludes the findings indicate a steroid-sparing effect with a time lag before the effect is attained.

Watch out: The headline conclusion rests on post-hoc sequential window-slicing: the pre-set whole-period comparison was not significant, and repeatedly re-testing overlapping windows inflates the chance of a false positive — the day-64 P = 0.04 should be read as hypothesis-generating. Both groups improved markedly, which is what prednisolone titration and trial participation themselves produce. Group sizes per arm are not stated in the abstract.

Saevik BK, Bergvall K, Holm BR, Saijonmaa-Koulumies LE, Hedhammar A, Larsen S, Kristensen F. A randomized, controlled study to evaluate the steroid sparing effect of essential fatty acid supplementation in the treatment of canine atopic dermatitis. Vet Dermatol. 2004;15(3):137-45. PMID: 15214949. Registry ID: none in the record. MeSH: Animals · Area Under Curve · Denmark · Dermatitis, Atopic · Dietary Supplements · Dog Diseases · Dogs · Double-Blind Method · Drug Administration Schedule · Fatty Acids, Essential · Female · Finland · Fish Oils · Glucocorticoids · Male · Norway · Plant Oils · Prednisolone · Sweden · Treatment Outcome · gamma-Linolenic Acid

Bond & Lloyd 1992: dogs controlled on evening primrose + fish oil deteriorated when switched to olive oil (8 of 10) vs 9 of 11 unchanged staying on the combination

Randomised double-blind parallel study (record's own abstract wording; indexed Randomized Controlled Trial, with MeSH Double-Blind Method)

Who: Dogs: atopic dogs whose clinical signs were already well controlled by dietary supplementation with a combination of evening primrose oil and fish oil, in a referral dermatology setting — 11 dogs continued the combination and 10 were switched to olive oil, over an eight-week randomised double-blind parallel study; plasma fatty acid concentrations were measured at the end of the study.

Result: Nine of the 11 dogs which continued to receive the evening primrose oil and fish oil combination were considered unchanged at the conclusion of the study, whereas eight of the 10 dogs switched to olive oil had deteriorated. The mean plasma concentration of dihomogammalinolenic acid was significantly reduced (P < 0.05) in the olive oil-treated group at the end of the study; there were no significant differences between the mean plasma linoleic, eicosapentaenoic and arachidonic acid concentrations in the two groups. The record concludes olive oil is not an effective therapeutic agent in the control of canine atopy.

Watch out: This is a withdrawal/substitution design in preselected responders — every dog entered already controlled on the supplement — so it shows the combination was maintaining control in those dogs, not that starting a supplement improves a new atopic patient; regression and natural fluctuation also push switched dogs to 'deteriorate'. Olive oil is the comparator, not an inert placebo, and the group sizes are 11 and 10.

Bond R, Lloyd DH. A double-blind comparison of olive oil and a combination of evening primrose oil and fish oil in the management of canine atopy. Vet Rec. 1992;131(24):558-60. PMID: 1481346. Registry ID: none in the record. MeSH: Animal Feed · Animals · Anti-Inflammatory Agents, Non-Steroidal · Dietary Fats, Unsaturated · Dog Diseases · Dogs · Double-Blind Method · Drug Combinations · Erythema · Fatty Acids, Essential · Female · Fish Oils · Hypersensitivity, Immediate · Linoleic Acids · Male · Oenothera biennis · Olive Oil · Plant Oils · Pruritus · Treatment Outcome · gamma-Linolenic Acid

Scarff & Lloyd 1992: evening primrose oil vs placebo crossover — significant treatment effect on erythema only (P < 0.05)

Double blind, placebo-controlled, crossover study (record's own title wording; MeSH Double-Blind Method)

Who: Dogs: 35 dogs with non-seasonal atopic dermatitis in a referral dermatology setting, in a double-blind, placebo-controlled crossover study of evening primrose (Oenothera biennis) oil; plasma phospholipid essential fatty acid levels were measured alongside the clinical signs.

Result: There was a significant treatment effect (P less than 0.05) on erythema. Analysis of plasma phospholipid essential fatty acid levels showed a significant (P less than 0.05) rise in linoleic acid concentration above that in the placebo group; arachidonic acid levels in the treated group increased significantly (P less than 0.005) in the first phase and also in the second phase (P less than 0.05), and in the second phase arachidonic acid levels differed significantly between active and placebo groups (P less than 0.05) with a significant treatment effect (P less than 0.05). The record's abstract reports no significant treatment effect on pruritus or other lesion scores.

Watch out: Only one clinical sign — erythema — reached significance, and most of the abstract's significant results are plasma lipid changes, which are evidence the oil was absorbed, not that dogs felt or looked better overall. A crossover in a fluctuating seasonal-adjacent disease is vulnerable to period effects; the record does not report washout handling in the abstract.

Scarff DH, Lloyd DH. Double blind, placebo-controlled, crossover study of evening primrose oil in the treatment of canine atopy. Vet Rec. 1992;131(5):97-9. PMID: 1523801. Registry ID: none in the record. MeSH: Animals · Arachidonic Acid · Dermatitis, Atopic · Dermatologic Agents · Dog Diseases · Dogs · Double-Blind Method · Fatty Acids, Essential · Linoleic Acid · Linoleic Acids · Oenothera biennis · Phospholipids · Plant Oils · gamma-Linolenic Acid

Synthesis: three blinded trials, three partial answers — a possible small effect on skin signs, steroid sparing unproven

Synthesis

Who: Synthesis of the cards above: Saevik 2004 (randomised double-blind placebo-controlled multicentre trial, 60 atopic dogs, fatty acids added to prednisolone); Bond & Lloyd 1992 (randomised double-blind withdrawal study, 21 atopic dogs previously controlled on evening primrose + fish oil); Scarff & Lloyd 1992 (double-blind placebo-controlled crossover, 35 atopic dogs, evening primrose oil).

Result: No carded trial shows a supplement beating placebo on its primary clinical comparison: steroid sparing missed significance over the full period (P = 0.32), erythema was the only sign to separate in the crossover, and the strongest-looking result (8 of 10 deteriorating off supplement) comes from dogs preselected as supplement responders. The consistent direction of the secondary signals — lower end-of-study scores in Saevik, maintained control in Bond & Lloyd, an erythema effect in Scarff & Lloyd — is enough to say a modest benefit in some dogs is possible, and supplements are a low-stakes adjunct; it is not enough to promise owners lesion, itch or coat improvement, or a lower steroid dose. Hence MAYBE (weak evidence).

Watch out: Products, doses and omega-3/omega-6 ratios differ across these trials (borage + fish oil; evening primrose + fish oil; evening primrose oil alone), so no single commercial supplement inherits even this weak stamp. Coat quality as such was not a reported endpoint in any carded record.

Synthesis of Saevik BK et al. PMID: 15214949; Bond R, Lloyd DH. PMID: 1481346; Scarff DH, Lloyd DH. PMID: 1523801. Registry IDs as on the individual cards.

Back to the library index · VetMed home

VetMed is an educational resource, not veterinary advice.